Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel Double Factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure

  • Rey Azpiri, Javier del|||0000-0001-7887-7871
  • Vidal, Francisco|||0000-0001-8089-4945
  • Ramírez, Lorena
  • Borràs, Nina
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Garcia, Iris
  • Martinez-Pasarell, Olga|||0000-0002-9760-2854
  • Fernandez, Silvia F.
  • Garcia-Cruz, Raquel|||0000-0002-6850-7575
  • Pujol, Aïda
  • Plaja Rustein, Alberto|||0000-0002-2398-1134
  • Salaverria Frigola, Itziar|||0000-0002-2427-9822
  • Oliver Bonet, Maria|||0000-0001-5635-6741
  • Benet i Català, Jordi|||0000-0001-6185-2555
  • Navarro i Ferreté, Joaquima|||0000-0002-9245-2260
In families at risk from monogenic diseases affected offspring, it is fundamental the development of a suitable Double Factor Preimplantation Genetic Testing (DF-PGT) method for both single-gene analysis and chromosome complement screening. Aneuploidy is not only a major issue in advanced-maternal-age patients and balanced translocation carriers, but also the aneuploidy rate is extremely high in patients undergoing in vitro fertilization (IVF), even in young donors. To adequate NGS technology to the DF-PGT strategy four different whole genome amplification systems (Sureplex, MALBAC, and two multiple displacement amplification systems-MDA) were tested using TruSight One panel on cell lines and blastocyst trophectoderm biopsies-TE. Embryo cytogenetic status was analyzed by Nexus software. Sureplex and MALBAC DNA products were considered not suitable for PGT diagnosis due to inconsistent and poor results on Trusight one (TSO) panel. Results obtained with both MDA based methods (GEH-MDA and RG-MDA) were appropriate for direct mutation detection by TSO NGS platform. Nevertheless, RG-MDA amplification products showed better coverage and lower ADO rates than GEH-MDA. The present work also demonstrates that the same TSO sequencing data is suitable not only for the direct mutation detection, but also for the indirect mutation detection by linkage analysis of informative SNPs. The present work also demonstrates that Nexus software is competent for the detection of CNV by using with TSO sequencing data from RG-MDA products, allowing for the whole cytogenetic characterization of the embryos. In conclusion, successfully development of an innovative and promising DF-PGT strategy using TSO-NGS technology in TE biopsies, performed in-house in a single laboratory experience, has been done in the present work. Additional studies should be performed before it could be used as a diagnostic alternative in order to validate this approach for the detection of chromosomal aneuploidies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Oligonucleotide Arrays vs. Metaphase-Comparative Genomic Hybridisation and BAC Arrays for Single-Cell Analysis, First Applications to Preimplantation Genetic Diagnosis for Robertsonian Translocation Carriers

  • Ramos Masdeu, Laia|||0000-0003-0869-8063
  • Rey Azpiri, Javier del|||0000-0001-7887-7871
  • Daina Noves, Gemma
  • García Aragonés, Manel
  • Armengol, Lluís
  • Fernandez Encinas, Alba|||0000-0003-2701-4739
  • Parriego, Mònica|||0000-0002-6459-3947
  • Boada i Palà, Montserrat|||0000-0003-0389-0638
  • Martinez-Pasarell, Olga|||0000-0002-9760-2854
  • Martorell, Maria Rosa
  • Casagran, Oriol
  • Benet i Català, Jordi|||0000-0001-6185-2555
  • Navarro i Ferreté, Joaquima|||0000-0002-9245-2260
Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CGH) and array-CGH are available for single-cell analysis. However, while metaphase-CGH and BAC array-CGH have been widely used for Preimplantation Genetic Diagnosis, oligonucleotide array-CGH has not been used in an extensive way. A comparison between oligonucleotide array-CGH and metaphase-CGH has been performed analysing 15 single fibroblasts from aneuploid cell-lines and 18 single blastomeres from human cleavage-stage embryos. Afterwards, oligonucleotide array-CGH and BAC array-CGH were also compared analysing 16 single blastomeres from human cleavage-stage embryos. All three comprehensive analysis techniques provided broadly similar cytogenetic profiles; however, non-identical profiles appeared when extensive aneuploidies were present in a cell. Both array techniques provided an optimised analysis procedure and a higher resolution than metaphase-CGH. Moreover, oligonucleotide array-CGH was able to define extra segmental imbalances in 14.7% of the blastomeres and it better determined the specific unbalanced chromosome regions due to a higher resolution of the technique (≈20 kb). Applicability of oligonucleotide array-CGH for Preimplantation Genetic Diagnosis has been demonstrated in two cases of Robertsonian translocation carriers 45,XY,der(13;14)(q10;q10). Transfer of euploid embryos was performed in both cases and pregnancy was achieved by one of the couples. This is the first time that an oligonucleotide array-CGH approach has been successfully applied to Preimplantation Genetic Diagnosis for balanced chromosome rearrangement carriers.